|
|||||||||||||||||||||||||||
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 43
Pharmacokinetics and Drug Interactions in the Elderly and Special Issues in Elderly African-American Populations: Workshop Summary
Appendix
Workshop Agenda, Speakers, and Participants
Pharmacokinetics and Drug Interactions in the Elderly and Special Issues in Elderly African-American Populations
Institute of Medicine
National Academy of Sciences
Committee on Pharmacokinetics and Drug Interactions in the Elderly
April 9, 1997
Xavier University of Louisiana
College of Pharmacy
New Orleans, LA
AGENDA
8:30–9:15 a.m.
Welcome
Marcellus Grace
Dean
College of Pharmacy
Xavier University of Louisiana
John Ruffin
Director
NIH Office of Research on Minority Health
J. Taylor Harden
Assistant to the Director for Special Populations
National Institute on Aging
Leslie Z. Benet, Committee Chair
University of California, San Francisco
OCR for page 44
Pharmacokinetics and Drug Interactions in the Elderly and Special Issues in Elderly African-American Populations: Workshop Summary
Definition of the Elderly Population
Janice Schwartz
Northwestern University Medical School
MORNING SESSION
State of the Science and Future Opportunities
9:15–10:00 a.m.
Physiology of Aging
What are the age, gender, race, disease, and environment related factors influencing physiology as they impact pharmacotherapy?
Overview
Fran E. Kaiser
St. Louis University
Hypertension in Elderly African Americans
Keith Ferdinand
Xavier University of Louisiana
10:00–11:00 a.m.
Intracellular Function
What are the age, gender, race, disease, and environment related factors influencing intracellular function as they impact pharmacotherapy?
Kinetics—Enzymes and Transport Proteins
Grant Wilkinson
Vanderbilt University
Receptors
Physiologic
Darrell R. Abernethy
Georgetown University Medical Center
Neurologic
Kurt Rasmussen
Eli Lilly and Company, Inc.
11:00–11:30 a.m.
DISCUSSION
OCR for page 45
Pharmacokinetics and Drug Interactions in the Elderly and Special Issues in Elderly African-American Populations: Workshop Summary
11:30 a.m.–12:15 p.m.
Response and Outcomes
What are the age, gender, race, disease, and environment related factors influencing response and outcomes?
Response
Jeffrey Halter
University of Michigan
Outcomes—Pharmacoepidemiology
Jane Cauley
University of Pittsburgh
Economics of Pharmacotherapy
Andy Stergachis
University of Washington
12:15–12:45 p.m.
DISCUSSION
12:45–1:30 p.m.
LUNCH
AFTERNOON SESSION
Resources and Opportunities
What are the barriers and opportunities related to age, gender, race, disease, and the environment in pharmacotherapy research?
1:30–2:30 p.m.
Recruitment of Study Participants
Defining the Study Population
Nanette Wenger
Emory University
Greg Sachs
University of Chicago
Issues in Recruiting and Retaining African
Americans in Clinical Trials
Techniques in Recruitment
Jackson Wright
Case Western University
Compliance and Other Issues
Richard Corriveau
Xavier University of Louisiana
OCR for page 46
Pharmacokinetics and Drug Interactions in the Elderly and Special Issues in Elderly African-American Populations: Workshop Summary
2:30–3:30 p.m.
Chronic Medication Use
Pharmaceuticals
Bruce Pollock
University of Pittsburgh
Nutraceuticals
Louis Lasagna
Tufts University
Methodology
Wayne Ray
Vanderbilt University
3:30–3:45 p.m.
BREAK
3:45–4:00 p.m.
Dissemination of Information to Prescribers, Pharmacists, Patients
Stephen Pauker
New England Medical Center
4:00–4:20 p.m.
Investigators/Funding
Jesse Roth
Johns Hopkins University School of Medicine
4:20–5:10 p.m.
DISCUSSION
5:10–5:30 p.m.
Summary
Marcus Reidenberg
Cornell University Medical Center
5:30 p.m.
Adjourn
OCR for page 47
Pharmacokinetics and Drug Interactions in the Elderly and Special Issues in Elderly African-American Populations: Workshop Summary
SPEAKERS
Darrell R. Abernethy
Francis Cabell Brown Professor of Medicine and Pharmacology
Director
Division of Clinical Pharmacology
Georgetown University Medical Center
Washington, DC
Leslie Z. Benet
Professor and Chairman
Department of Biopharmaceutical Sciences
University of California, San Francisco
San Francisco, CA
Jane Cauley
Associate Professor
Graduate School of Public Health
University of Pittsburgh
Pittsburgh, PA
Richard Corriveau
Director, Clinical Trials Unit
College of Pharmacy
Xavier University of Louisiana
New Orleans, LA
Keith Ferdinand
Associate Professor, Clinical Pharmacology
Medical Director, Heartbeats Life Center
College of Pharmacy
Xavier University of Louisiana
New Orleans, LA
Marcellus Grace
Dean
College of Pharmacy
Xavier University of Louisiana
New Orleans, LA
Jeffrey Halter
Director
University of Michigan Geriatrics Center
Ann Arbor, MI
J. Taylor Harden
Assistant Director for Special Populations
National Institute on Aging
Bethesda, MD
Fran E. Kaiser
Professor of Medicine
Division of Geriatric Medicine
St. Louis University Medical Center
St. Louis, MO
Louis Lasagna
Dean for Scientific Affairs
Tufts University School of Medicine
Boston, MA
Stephen G. Pauker
Vice-Chairman for Clinical Affairs
Department of Medicine
New England Medical Center
Boston, MA
OCR for page 48
Pharmacokinetics and Drug Interactions in the Elderly and Special Issues in Elderly African-American Populations: Workshop Summary
Bruce Pollock
Professor of Psychiatry and Pharmacology
University of Pittsburgh School of Medicine
Pittsburgh, PA
Kurt Rasmussen
Neuroscience Research
Therapeutic Area Discovery Research and Clinical Investigation
Eli Lilly & Company, Inc.
Indianapolis, IN
Wayne Ray
Professor
Department of Preventive Medicine and Public Health
Vanderbilt University School of Medicine
Nashville, TN
Marcus M. Reidenberg
Clinical Pharmacology and Therapeutics
Cornell University Medical Center
New York, NY
Jesse Roth
Raymond and Anna Lublin Professor of Medicine
Director, Division of Geriatric Medicine
Johns Hopkins University School of Medicine
Baltimore, MD
John Ruffin
Director
Office of Research on Minority Health
National Institutes of Health
Bethesda, MD
Greg A. Sachs
Assistant Professor of Medicine
University of Chicago Medical Center
Chicago, IL
Janice B. Schwartz
Professor of Medicine
Chief of Clinical Pharmacology and Geriatric Medicine
Northwestern University Medical School
Chicago, IL
Andy Stergachis
Professor of Pharmacy and Epidemiology
Chairman, Department of Pharmacy
University of Washington School of Pharmacy
Seattle, WA
Nanette Wenger
Professor of Medicine, Cardiology
Emory University School of Medicine
Atlanta, GA
Grant R. Wilkinson
Professor of Pharmacology
Associate Director, Division of Clinical Pharmacology
Vanderbilt University School of Medicine
Nashville, TN
Jackson T. Wright
Director, Clinical Hypertension Program
Department of Medicine
Case Western Reserve University
Cleveland, OH
OCR for page 49
Pharmacokinetics and Drug Interactions in the Elderly and Special Issues in Elderly African-American Populations: Workshop Summary
PARTICIPANTS
Edwin H. Adams
School of Pharmacy
Northeast Louisiana University
West Monroe, LA
Theodore R. Bates
Professor of Pharmaceutics
Texas Southern University
Houston, TX
Mark H. Beers
Senior Director of Geriatrics
Merck & Co., Inc.
West Point, PA
Levon Bostinian
Assistant Professor
College of Pharmacy
Xavier University of Louisiana
New Orleans, LA
D. Craig Brater
Chairman
Department of Medicine
Indiana University School of Medicine
Indianapolis, IN
Louise Cheung
Assistant Professor of Pharmaceutics
Texas Southern University
Houston, TX
Janice L. Feinberg
Director
American Society of Consultant Pharmacists (ASCP) Foundation
Alexandria, VA
David J. Greenblatt
Professor and Chairman
Department of Pharmacology and Experimental Therapeutics
Tufts University
Boston, MA
Barbara E. Hayes
College of Pharmacy and Health Sciences
Texas Southern University
Houston, TX
Burde Kamath
Associate Professor
Biopharmaceutics and Pharmacokinetics
College of Pharmacy
Xavier University of Louisiana
New Orleans, LA
Patricia D. Kroboth
Professor and Chair
Department of Pharmaceutical Sciences
University of Pittsburgh School of Pharmacy
Pittsburgh, PA
Catharyn T. Liverman
Program Officer
Institute of Medicine
Washington, D.C.
Henri R. Manasse, Jr.
Executive Vice President
American Society of Health System Pharmacists
Bethesda, MD
OCR for page 50
Pharmacokinetics and Drug Interactions in the Elderly and Special Issues in Elderly African-American Populations: Workshop Summary
C. David Matthews
Assistant Professor
Clinical Practice
Northeast Louisiana University
West Monroe, LA
Joseph M. Moerschbaecher
Professor and Head
Department of Pharmacology
Louisiana State University Medical Center
New Orleans, LA
Mark Monane
Director
Disease State Management-Geriatrics
Merck Medco Managed Care
Montvale, NJ
Constance M. Pechura
Director
Division of Neuroscience and Behavioral Health
Institute of Medicine
Washington, D.C.
Judith A. Salerno
Chief Consultant
Geriatrics and Extended Care
Department of Veterans Affairs
Washington, DC
Daniel Sarpong
ssistant Professor of Biostatistics
College of Pharmacy
Xavier University of Louisiana
New Orleans, LA
Marvin Scott
Assistant Professor, Pharmacy Practice
College of Pharmacy and Pharmaceutical Sciences
Florida A&M University
Tallahassee, FL
Stanley Slater
eputy Associate Director Geriatrics Program
National Institute on Aging
Washington, DC
Robert Taylor
Chairman
Department of Pharmacology
Howard University College of Medicine
Washington, DC
Vasant Telang
Interim Dean
College of Pharmacy
Howard University
Washington, DC
Alice E. Till
Vice President for Scientific Affairs
Generic Pharmaceutical Industry Association
Washington, DC
Representative terms from entire chapter:
drug interactions